Evaluation of Sixth-Generation High-Sensitivity Cardiac Troponin T Test to Improve Early Diagnosis and Management of Suspected Heart Attacks

What this Trial Is About

Researchers are evaluating a new sixth-generation high-sensitivity cardiac troponin T test to diagnose heart attacks more quickly among patients with suspected acute coronary syndrome. This diagnostic study aims to determine if using this advanced test reduces the time patients spend in Emergency Departments while maintaining patient safety. The study compares data from one year before and one year after introducing the new test across a health board, using routinely collected hospital data and blood samples. The study involves two groups patients evaluated with the current fifth-generation troponin test before the new tests implementation, and those evaluated with the sixth-generation test afterward. The sixth-generation Elecsys Troponin T hs Gen 6 assay is designed to be more precise and less affected by interference than the previous version. Researchers will measure troponin levels from surplus blood samples collected during two six-month periods before and after the new tests introduction to directly compare the tests. Participants will not need to take any extra actions as the study uses data and samples collected during usual care. Researchers will examine Emergency Department length of stay as the primary outcome, along with hospital admission, cardiovascular events, and mortality up to one year. The study will also monitor serial troponin measurements and other clinical outcomes to assess the new tests impact on patient care and safety over time.

Sixth Generation High-sensitivity Cardiac Troponin T for the Early Rule Out of Myocardial Infarction: a Controlled Before and After Study